The CONSORT-EHEALTH checklist is intended for authors of randomized trials evaluating webbased and Internet-based applications/interventions, including mobile interventions, electronic games (incl multiplayer games), social media, certain telehealth applications, and other interactive and/or networked electronic applications. Some of the items (e.g. all subitems under item 5description of the intervention) may also be applicable for other study designs.
yes: all primary outcomes were signi cantly better in intervention group vs control partly: SOME primary outcomes were signi cantly better in intervention group vs control no statistically signi cant difference between control and intervention potentially harmful: control was signi cantly better than intervention in one or more outcomes inconclusive: more research is needed Other:
not submitted yet -in early draft status not submitted yet -in late draft status, just before submission submitted to a journal but not reviewed yet submitted to a journal and after receiving initial reviewer comments submitted to a journal and accepted, but not published yet If you already know where you will submit this paper (or if it is already submitted), please provide the journal name (if it is not JMIR, provide the journal name under "other") Is this a full powered effectiveness trial or a pilot/feasibility trial? * Manuscript tracking number * If this is a JMIR submission, please provide the manuscript tracking number under "other" (The ms tracking number can be found in the submission acknowledgement email, or when you login as author in JMIR. If the paper is already published in JMIR, then the ms tracking number is the fourdigit number at the end of the DOI, to be found at the bottom of each published article in JMIR) 1a) Does your paper address CONSORT item 1a? * I.e does the title contain the phrase "Randomized Controlled Trial"? (if not, explain the reason under "other") 1a-i) Identify the mode of delivery in the title Identify the mode of delivery. Preferably use "web-based" and/or "mobile" and/or "electronic game" in the title. Avoid ambiguous terms like "online", "virtual", "interactive". Use "Internet-based" only if Intervention includes non-web-based Internet components (e.g. email), use "computer-based" or "electronic" only if o ine products are used. Use "virtual" only in the context of "virtual reality" (3-D worlds). Use "online" only in the context of "online support groups". Complement or substitute product names with broader terms for the class of products (such as "mobile" or "smart phone" instead of "iphone"), especially if the application runs on different platforms.
Does your paper address subitem 1a-i? * Copy and paste relevant sections from manuscript title (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Mention non-web-based components or important co-interventions in title, if any (e.g., "with telephone support").
Does your paper address subitem 1a-ii?
Copy and paste relevant sections from manuscript title (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study
Your answer 1a-iii) Primary condition or target group in the title Copy and paste relevant sections from the manuscript abstract (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study
Your answer 2a-i) Problem and the type of system/solution
Describe the problem and the type of system/solution that is object of the study: intended as standalone intervention vs. incorporated in broader health care program? Intended for a particular patient population? Goals of the intervention, e.g., being more cost-effective to other interventions, replace or complement other solutions? (Note: Details about the intervention are provided in "Methods" under 5) Does your paper address subitem 2a-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "As one of the leading causes of maternal morbidity [2], postnatal depression (PND) has an approximate global prevalence of 10% to 15% ...Postnatal depression has garnered much attention due to its potential contribution to maternal mortality and its ripple effects on the family unit...Social support has long been proven to buffer stress and promote healthy psychological wellbeing...This suggests that a support system involving sharing with another experienced mother who has undergone similar situations can potentially meet mothers' needs in terms of empathy and having a non-judgmental listening ear." 2a-ii) Scienti c background, rationale: What is known about the (type of) system Scienti c background, rationale: What is known about the (type of) system that is the object of the study (be sure to discuss the use of similar systems for other conditions/diagnoses, if appropiate), motivation for the study, i.e. what are the reasons for and what is the context for this speci c study, from which stakeholder viewpoint is the study performed, potential impact of ndings [2] . Brie y justify the choice of the comparator. Does your paper address subitem 2a-ii? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "Numerous studies identi ed help-seeking barriers among women at risk of psychological issues, namely lack of knowledge, practical barriers (e.g. nancial di culties and work), and attitudinal barriers (e.g. stigma) [21, 26, 27] . In a conservative multi-racial country like Singapore, traditional views and homebound con nement practices serve as additional help-seeking barriers. Therefore, technology-based interventions are an ideal alternative to increase local women's accessibility to professional help and improve maternal outcomes [28, 29] Additionally, Sjoberg and colleagues' study [37] revealed that the new generation of mothers preferred online peer-support over face-to-face or online consultations with healthcare professionals. Therefore, there is a need to adopt a technology-based approach and paraprofessional peer support to effectively meet the desires of new generation mothers in Singapore. "
Does your paper address CONSORT subitem 2b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "the current study aims to examine the effectiveness of a technology-based peer-support intervention program (PIP) among mothers at risk of postnatal depression during the early postpartum period (three months postpartum). Secondary maternal outcomes examined were PNA, loneliness, and perceived social support. The hypothesis is that, compared to the control group, mothers in the intervention group will report signi cantly lower scores for PND, PNA, and loneliness and higher scores for perceived social support at 12 weeks postpartum."
Does your paper address CONSORT subitem 3a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "The present study adopted a randomized-controlled, Does your paper address subitem 3b-i?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study
Your answer
Does your paper address CONSORT subitem 4a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "Peer volunteers inclusion criteria: i) mothers who were at least 21 years old, ii) pro cient in verbal and written English, iii) delivered a healthy baby in the past, iv) had a self-reported history of and recovery from PND, v) had a mobile phone and were willing to share their number and call needy mothers as instructed by the research team, and vi) planned to stay in Singapore for the next six months after recruitment to administer the peer-support intervention. Peer volunteers were excluded if they had any physical or mental conditions that interfered with their ability to participate in the study. Mothers at risk of PND were recruited from the postnatal wards of a local tertiary hospital immediately post-birth based on the following inclusion criteria: i) were at least 21 years old, ii) could read and speak English, iii) owned a mobile phone and were willing to share their number, iv) planned to stay in Singapore for three months post birth, v) delivered a healthy baby without birth defects and/or medical complications, and vi) had a baseline Edinburg Postnatal Depression Scores (EPDS) of more than or equal to nine. Mothers were excluded if i) they had a history of existing psychiatric illness, cognitive impairment, and/or major medical conditions that could interfere their abilities to participate in the study and/or ii) had a vacuum-or forceps-assisted delivery with a fourth-degree perineal tear."
4a-i) Computer / Internet literacy
Computer / Internet literacy is often an implicit "de facto" eligibility criterion -this should be explicitly clari ed.
Does your paper address subitem 4a-i?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Open vs. closed, web-based vs. face-to-face assessments: Mention how participants were recruited (online vs. o ine), e.g., from an open access website or from a clinic, and clarify if this was a purely web-based trial, or there were face-to-face components (as part of the intervention or for assessment), i.e., to what degree got the study team to know the participant. In online-only trials, clarify if participants were quasi-anonymous and whether having multiple identities was possible or whether technical or logistical measures (e.g., cookies, email con rmation, phone calls) were used to detect/prevent these.
Does your paper address subitem 4a-ii? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "Peer volunteers were recruited through a blasting of emails to the study venue's working community and by word of mouth...Mothers at risk of PND were recruited from the postnatal wards of a local tertiary hospital immediately postbirth." 4a-iii) Information giving during recruitment Information given during recruitment. Specify how participants were briefed for recruitment and in the informed consent procedures (e.g., publish the informed consent documentation as appendix, see also item X26), as this information may have an effect on user self-selection, user expectation and may also bias results.
Does your paper address subitem 4a-iii?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer Does your paper address CONSORT subitem 4b? *
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "The study was conducted from May 2017 to May 2018 at a local tertiary hospital, National University Hospital, in Singapore."
4b-i) Report if outcomes were (self-)assessed through online questionnaires Clearly report if outcomes were (self-)assessed through online questionnaires (as common in webbased trials) or otherwise.
Does your paper address subitem 4b-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "The demographic data of the mothers were collected at the baseline using a self-reported questionnaire. PND (primary outcome), PNA, loneliness, and perceived social support (secondary outcomes) were measured using a selfreported face-to-face questionnaire at the baseline and via web-based questionnaires at the fourth and twelfth week postpartum." subitem not at all important Does your paper address subitem 4b-ii?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer 5-i) Mention names, credential, a liations of the developers, sponsors, and owners Mention names, credential, a liations of the developers, sponsors, and owners [6] (if authors/evaluators are owners or developer of the software, this needs to be declared in a "Con ict of interest" section or mentioned elsewhere in the manuscript).
Does your paper address subitem 5-i?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer 5-ii) Describe the history/development process Describe the history/development process of the application and previous formative evaluations (e.g., focus groups, usability testing), as these will have an impact on adoption/use rates and help with interpreting results.
Does your paper address subitem 5-ii?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer
5-iii) Revisions and updating
Revisions and updating. Clearly mention the date and/or version number of the application/intervention (and comparator, if applicable) evaluated, or describe whether the intervention underwent major changes during the evaluation process, or whether the development and/or content was "frozen" during the trial. Describe dynamic components such as news feeds or changing content which may have an impact on the replicability of the intervention (for unexpected events see item 3b).
Does your paper address subitem 5-iii?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Does your paper address subitem 5-iv?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer 5-v) Ensure replicability by publishing the source code, and/or providing screenshots/screen-capture video, and/or providing owcharts of the algorithms used Ensure replicability by publishing the source code, and/or providing screenshots/screen-capture video, and/or providing owcharts of the algorithms used. Replicability (i.e., other researchers should in principle be able to replicate the study) is a hallmark of scienti c reporting.
Does your paper address subitem 5-v?
5-vi) Digital preservation
Digital preservation: Provide the URL of the application, but as the intervention is likely to change or disappear over the course of the years; also make sure the intervention is archived (Internet Archive, webcitation.org, and/or publishing the source code or screenshots/videos alongside the article). As pages behind login screens cannot be archived, consider creating demo pages which are accessible without login.
Does your paper address subitem 5-vi?
5-vii) Access
Access: Describe how participants accessed the application, in what setting/context, if they had to pay (or were paid) or not, whether they had to be a member of speci c group. If known, describe how participants obtained "access to the platform and Internet" [1]. To ensure access for editors/reviewers/readers, consider to provide a "backdoor" login account or demo mode for reviewers/readers to explore the application (also important for archiving purposes, see vi). was prepared and given to each peer volunteer for future references. The PIP intervention involved correspondence with a trained peer volunteer at least once a week (for four weeks) via phone calls, emails, or mobile communication applications (e.g. WhatsApp), depending on each mother's preference and convenience. Peer volunteers were encouraged to keep a free text journal of their conversations, and the intensity and duration of each correspondence were recorded in an activity log. "
5-ix) Describe use parameters
Describe use parameters (e.g., intended "doses" and optimal timing for use). Clarify what instructions or recommendations were given to the user, e.g., regarding timing, frequency, heaviness of use, if any, or was the intervention used ad libitum.
Does your paper address subitem 5-ix?
5-x) Clarify the level of human involvement
Clarify the level of human involvement (care providers or health professionals, also technical assistance) in the e-intervention or as co-intervention (detail number and expertise of professionals involved, if any, as well as "type of assistance offered, the timing and frequency of the support, how it is initiated, and the medium by which the assistance is delivered". It may be necessary to distinguish between the level of human involvement required for the trial, and the level of human involvement required for a routine application outside of a RCT setting (discuss under item 21generalizability).
Does your paper address subitem 5-x?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer subitem not at all important 1 2 3 4 5 essential subitem not at all important 1 2 3 4 5 essential 6a) Completely de ned pre-speci ed primary and secondary outcome measures, including how and when they were assessed 5-xi) Report any prompts/reminders used Report any prompts/reminders used: Clarify if there were prompts (letters, emails, phone calls, SMS) to use the application, what triggered them, frequency etc. It may be necessary to distinguish between the level of prompts/reminders required for the trial, and the level of prompts/reminders for a routine application outside of a RCT setting (discuss under item 21 -generalizability).
Does your paper address subitem 5-xi? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study
Follow up text messgaes were sent if participants forgot to reply the peer volunteers. Does your paper address CONSORT subitem 6a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "The demographic data of the mothers were collected at the baseline using a self-reported questionnaire. PND (primary outcome), PNA, loneliness, and perceived social support (secondary outcomes) were measured using a selfreported face-to-face questionnaire at the baseline and via web-based questionnaires at the fourth and twelfth week postpartum. The internal consistency of each instrument was measured using Cronbach's alpha.PND was measured using the 10-item Edinburgh Postnatal Depression Scale (EPDS) [41] . The total score ranges from 0 to 30, with a higher score indicating a higher risk of PND. Based on previous trials [35, 42] , a recommended cut-off score of nine was used to screen mothers at risk of PND and a score of more than 13 as a probable diagnosis for PND. The internal consistencies at the baseline, four weeks postpartum, and 12 weeks postpartum were 0.59, 0.87, and 0.86, respectively.
5-xii)
The nine-item Patient Health Questionnaire (PHQ-9) [43] was extracted from the full PHQ used to diagnose and measure the severity of major depression. The total score ranges from 0 to 27, with a higher score indicating a higher severity of PND. The Cronbach's alpha values for this study were 0.83, 0.86, and 0.92 for baseline, four weeks and 12 weeks postpartum. The State-Trait Anxiety Inventory (STAI) [44], a 40-item questionnaire using a four-point Likert scale, was used to measure maternal anxiety. The total score ranges from 40 to 160, with a higher score suggesting a higher severity of anxiety. The STAI had high internal consistencies of 0.96, 0.97, and 0.98 for the baseline, four weeks postpartum, and 12 weeks postpartum, respectively. Loneliness was measured using the 10-item University of California, Los Angeles Loneliness Scale (ULS) [45] . Items are rated on a four-point Likert scale, with the total score ranging from 10 to 40. A higher score represents a higher level of loneliness. The ULS had high internal consistencies of 0.96, 0.97, and 0.97 at the baseline, four weeks postpartum, and 12 weeks postpartum, respectively, in this study. The Perceived Social Support for Parenting (PSSP) instrument developed by Leerkes and Crockenberg [46] was used to measure maternal satisfaction of the social support received from partners and others during the postpartum period. The instrument had a 5-point Likert scale and two 4-item subparts: i) social support received from partner and ii) social support received from others. The total score ranges from 5 to 40, with a higher score implying a higher level of satisfaction of the received social support. The Cronbach's alpha values for baseline, four weeks postpartum and 12 weeks postpartum were 0.93, 0.89, and 0.92. Detailed descriptions of the instruments can be found in the study protocol [39] ." 6a-i) Online questionnaires: describe if they were validated for online use and apply CHERRIES items to describe how the questionnaires were designed/deployed If outcomes were obtained through online questionnaires, describe if they were validated for online use and apply CHERRIES items to describe how the questionnaires were designed/deployed [9].
Does your paper address subitem 6a-i? Does your paper address CONSORT subitem 8a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "Participants were randomized into two groups (69 couples in each group) using an opaque envelope containing non-duplicated numbers generated from a research randomizer" (stated in protocol)
Does your paper address CONSORT subitem 8b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study simple randomisation (in protocol) Does your paper address CONSORT subitem 9? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "Participants were randomized into two groups (69 couples in each group) using an opaque envelope containing non-duplicated numbers generated from a research randomizer" (in protocol) Does your paper address CONSORT subitem 10? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "Random allocation sequence was generated by a research randomizer " by the principal investigator, the rst research assistant enrolled and assigned the participants to intervention 11a-i) Specify who was blinded, and who wasn't Specify who was blinded, and who wasn't. Usually, in web-based trials it is not possible to blind the participants [1, 3] (this should be clearly acknowledged), but it may be possible to blind outcome assessors, those doing data analysis or those administering co-interventions (if any).
Does your paper address subitem 11a-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "The research assistant who was responsible for data collection was blinded to the group allocation of the participants." 11a-ii) Discuss e.g., whether participants knew which intervention was the "intervention of interest" and which one was the "comparator"
Informed consent procedures (4a-ii) can create biases and certain expectations -discuss e.g., whether participants knew which intervention was the "intervention of interest" and which one was the "comparator".
Does your paper address subitem 11a-ii?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer Does your paper address CONSORT subitem 11b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study not relevant Does your paper address CONSORT subitem 12a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "All analyses were conducted using the IBM SPSS v24.0 with the statistical signi cance set at P<0.05. The analysis was performed on the intention-to-treat population. Descriptive statistics were presented as mean (SD) and n (%) for continuous and categorical variables, respectively. When normality and homogeneity assumptions were satis ed, the independent sample t-test was used to compare the differences of continuous variables between the two groups, or else the Mann-Whitney U test was used. Comparisons of categorical variables were performed using Chi-square or Fisher's exact test.
A linear mixed-effect model was used to compare the average means of PND, PNA, loneliness, and social support between groups across the baseline and at four weeks and 12 weeks postpartum." 12a-i) Imputation techniques to deal with attrition / missing values Imputation techniques to deal with attrition / missing values: Not all participants will use the intervention/comparator as intended and attrition is typically high in ehealth trials. Specify how participants who did not use the application or dropped out from the trial were treated in the statistical analysis (a complete case analysis is strongly discouraged, and simple imputation techniques such as LOCF may also be problematic [4] Does your paper address subitem 12a-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Missing data will be replaced (assuming 10%) for intention-to-treat analysis.
Both intention-to-treat analysis and per-protocol analysis will be conducted to compare any differences between groups Does your paper address CONSORT subitem 12b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "A sensitivity analysis was conducted using the same model (linear mixedeffect), adjusting for age, ethnicity, marital status, antenatal class attendance, type of birth delivery, baby's gender, baby's birth order, maternity leave, and con nement period. "
X26-i) Comment on ethics committee approval
Does your paper address subitem X26-i?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer x26-ii) Outline informed consent procedures Outline informed consent procedures e.g., if consent was obtained o ine or online (how? Checkbox, etc.?), and what information was provided (see 4a-ii). See [6] for some items to be included in informed consent documents.
Does your paper address subitem X26-ii?
X26-iii) Safety and security procedures
Safety and security procedures, incl. privacy considerations, and any steps taken to reduce the likelihood or detection of harm (e.g., education and training, availability of a hotline) Does your paper address subitem X26-iii?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Does your paper address CONSORT subitem 13a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "A total of 138 mothers were recruited and randomized into the control (n=69) and intervention (n=69) groups...Follow-up assessments at four weeks postpartum were completed for all mothers in both the control (n=69) and intervention (n=69) groups. At 12 weeks postpartum, follow-up assessments were completed for 55 mothers from the intervention group (79.7%) and 58 mothers from the control group (84.1%). The overall attrition rate was 18.1%."
Does your paper address CONSORT subitem 13b? (NOTE: Preferably, this is shown in a CONSORT ow diagram) * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study in the CONSORT owchart provided 13b-i) Attrition diagram Strongly recommended: An attrition diagram (e.g., proportion of participants still logging in or using the intervention/comparator in each group plotted over time, similar to a survival curve) or other gures or tables demonstrating usage/dose/engagement.
Does your paper address subitem 13b-i?
Copy and paste relevant sections from the manuscript or cite the gure number if applicable (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer Does your paper address CONSORT subitem 14a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "The study was conducted from May 2017 to May 2018 at a local tertiary hospital, National University Hospital, in Singapore." Data collection took place immediately postpartum, 4 weeks postpartum, and 12 weeks postpartum.
14a-i) Indicate if critical "secular events" fell into the study period Indicate if critical "secular events" fell into the study period, e.g., signi cant changes in Internet resources available or "changes in computer hardware or Internet delivery resources" Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer Does your paper address CONSORT subitem 14b? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study
Not relevant
Does your paper address CONSORT subitem 15? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study reported in Table 1 .
15-i) Report demographics associated with digital divide issues
In ehealth trials it is particularly important to report demographics associated with digital divide issues, such as age, education, gender, social-economic status, computer/Internet/ehealth literacy of the participants, if known.
Does your paper address subitem 15-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study reported in Table 1. 16-i) Report multiple "denominators" and provide de nitions Report multiple "denominators" and provide de nitions: Report N's (and effect sizes) "across a range of study participation [and use] thresholds" [1], e.g., N exposed, N consented, N used more than x times, N used more than y weeks, N participants "used" the intervention/comparator at speci c pre-de ned time points of interest (in absolute and relative numbers per group). Always clearly de ne "use" of the intervention.
Does your paper address subitem 16-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study ". Follow-up assessments at four weeks postpartum were completed for all mothers in both the control (n=69) and intervention (n=69) Primary analysis should be intent-to-treat, secondary analyses could include comparing only "users", with the appropriate caveats that this is no longer a randomized sample (see 18-i).
Does your paper address subitem 16-ii?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer Does your paper address CONSORT subitem 17a? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "The mean outcome scores of the intervention and control groups for each timepoint are summarized in Table 2 . Based on literature and the level of signi cance, the outcome measures were adjusted for age, ethnicity, marital status, antenatal class attendance, type of birth delivery, baby's gender, baby's birth order, maternity leave, and con nement period. PND was measured using the EPDS and the PHQ. The mean EPDS scores from the baseline to 12 weeks postpartum were 9.9 (SD=0.4) for the intervention group and 10.4 (SD=0.4) for the control group. Overall, the intervention group had a lower mean EPDS score than the control group, with a statistically signi cant percentage change between groups at 12 weeks postpartum after adjustment (mean difference [d]=0.15; 95% con dence interval [CI]=-1.33, 1.64; P=.02). Likewise for the PHQ scores, both groups had relatively low mean scores, with the intervention group scoring a lower mean of 5.8 (SD=0.5) than the control group (6.6, SD=0.5), but the percentage change difference for the PHQ scores from the baseline to 12 weeks postpartum was not statistically signi cant between the two groups even after adjustment (d=-0.31; 95% CI=-2.10, 1.48; P=0.19).
For the STAI scores, the intervention group had a lower mean of 78.8 (SD=2.4) than the control group's mean of 83.5 (SD=2.4). Despite the seemingly large difference in mean scores for the STAI, the percentage change difference between groups was not statistically signi cant (d=-2.47; 95% CI=-11.17, 6.24; P=0.09).
The mean ULS scores for the intervention and control groups from the baseline to 12 weeks postpartum were similarly high, with mean scores of 36.3 (SD=1.5) and 36.5 (SD=1.5), respectively. However, the change between groups was not statistically signi cant (d=-0.70; 95% 4.44; P=0.14) .
The mean scores for perceived social support were high for both groups, with the control group having a slightly higher mean of 32.3 (SD=0.7) than the intervention group (31.1, SD=0.7). When comparing both groups, there was no statistically signi cant percentage change in scores from the baseline to 12 weeks postpartum (d=-1.63; 95% 0.89; P=0.20) ." 17a-i) Presentation of process outcomes such as metrics of use and intensity of use
In addition to primary/secondary (clinical) outcomes, the presentation of process outcomes such as metrics of use and intensity of use (dose, exposure) and their operational de nitions is critical. This does not only refer to metrics of attrition (13-b) (often a binary variable), but also to more continuous exposure metrics such as "average session length". These must be accompanied by a technical description how a metric like a "session" is de ned (e.g., timeout after idle time) [1] (report under item 6a). 22-i) Restate study questions and summarize the answers suggested by the data, starting with primary outcomes and process outcomes (use)
Restate study questions and summarize the answers suggested by the data, starting with primary outcomes and process outcomes (use).
Does your paper address subitem 22-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "The present study examined the effectiveness of a technology-based PIP among mothers at risk of PND. According to the score trend, the intervention group scored better than the control group for all maternal outcomes at both four and 12 weeks postpartum, but only the mean difference in the EPDS scores between groups was shown to be statistically signi cant. This suggests that, compared to mothers who only received routine hospital care, the PIP was generally effective in reducing the risks of PND, PNA, and loneliness and increasing perceived social support received by the end of 12 weeks postpartum." Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer
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20-i) Typical limitations in ehealth trials
Typical limitations in ehealth trials: Participants in ehealth trials are rarely blinded. Ehealth trials often look at a multiplicity of outcomes, increasing risk for a Type I error. Discuss biases due to non-use of the intervention/usability issues, biases through informed consent procedures, unexpected events.
Does your paper address subitem 20-i? * Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study "However, a limitation of this study is that it was a single-site study, targeting only English-speaking mothers. Another limitation is that the intervention was only administered during the postpartum period. Additionally, maternal outcomes included in this study were limited and infant outcomes were lacking."
21-i) Generalizability to other populations
Generalizability to other populations: In particular, discuss generalizability to a general Internet population, outside of a RCT setting, and general patient population, including applicability of the study results for other organizations Does your paper address subitem 21-i?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer 21-ii) Discuss if there were elements in the RCT that would be different in a routine application setting Discuss if there were elements in the RCT that would be different in a routine application setting (e.g., prompts/reminders, more human involvement, training sessions or other co-interventions) and what impact the omission of these elements could have on use, adoption, or outcomes if the intervention is applied outside of a RCT setting.
Does your paper address subitem 21-ii?
Copy and paste relevant sections from the manuscript (include quotes in quotation marks "like this" to indicate direct quotes from your manuscript), or elaborate on this item by providing additional information not in the ms, or brie y explain why the item is not applicable/relevant for your study Your answer 10/4/2018 CONSORT-EHEALTH (V 1.6.1) - In addition to the usual declaration of interests ( nancial or otherwise), also state the relation of the study team towards the system being evaluated, i.e., state if the authors/evaluators are distinct from or identical with the developers/sponsors of the intervention.
Does your paper address subitem X27-i?
Your answer
As a result of using this checklist, did you make changes in your manuscript? * STOP -Save this form as PDF before you click submit
To generate a record that you lled in this form, we recommend to generate a PDF of this page (on a Mac, simply select "print" and then select "print as PDF") before you submit it.
When you submit your (revised) paper to JMIR, please upload the PDF as supplementary le.
Don't worry if some text in the textboxes is cut off, as we still have the complete information in our database. Thank you! 
